Beauty

Shiseido to Sell China's Aupres Owner SLC to IDG-Led Consortium

Mira SolenNovember 19, 20265 min read0 views

At a glance

  • The Japanese beauty group is divesting its Chinese subsidiary as it pursues higher profitability and capital efficiency under its 2030 strategy.
  • Shiseido has signed a binding agreement to sell Shiseido Liyuan Cosmetics, the Chinese maker and seller of the Aupres brand, to an IDG Capital-led investor consortium. The transaction, expected to close between the fourth quarter of 2026 and the first quarter of 2027, includes a Beijing factory and transitional IP licensing and supply support.
A frosted-glass cosmetic bottle on a minimalist executive table is linked by a lit pathway to a miniature factory and translucent investment tokens, suggesting a cross-border business handover.

Shiseido has signed a binding agreement to sell its Chinese subsidiary, Shiseido Liyuan Cosmetics (SLC), to an investor consortium led by Hong Kong-headquartered private equity firm IDG Capital. SLC makes and sells the Aupres brand in China. Financial terms were not disclosed.

The deal is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals, including in China. Under the transaction, funds managed by IDG Capital will hold 95% of the equity through two special purpose vehicles, while a limited partnership enterprise set up mainly by SLC’s new management team will hold the remaining 5%. The sale includes SLC’s Beijing factory and production equipment.

Shiseido frames the divestment as part of its 2030 Medium-Term Strategy to improve profitability and capital efficiency. The group says it wants to drive sustainable growth and strengthen its competitiveness in China by focusing management resources on areas where it “enjoys the greatest competitive advantage.” It also aims to concentrate on priority brands and higher-growth opportunities. Shiseido describes China as a strategically important and attractive, dynamic market where competition continues to evolve amid rapid e-commerce expansion, changing consumer behavior and the emergence of diverse market participants.

According to Shiseido, the sale sheds a business that needs continued investment in product innovation and digital capabilities. The company expects independent operation under IDG to support SLC’s sustainable growth and brand value.

SLC was established in 1991 as a joint venture with Beijing Liyuan, a subsidiary of Yiqing Group, which is owned by the Beijing Municipal Government. The company has sold the C-beauty brand Aupres since 1994. With the joint venture agreement due to expire in December 2026, the parties agreed not to renew it. On September 1, 2026, Shiseido acquired Beijing Liyuan’s 35% stake, giving it full ownership ahead of the sale.

To support the handover, Shiseido will license the intellectual property rights IDG needs to run the business. For a specified period after the transfer, Shiseido will provide ongoing support on new product development, technical assistance for the stable supply of existing products, and continued supply of raw materials and selected products. The company says the transitional collaboration aims to maintain SLC’s innovation capabilities, product quality and business continuity.

The divestment comes days after Shiseido reported a 124.3% jump in core operating profit for the third quarter of 2026, to ¥67.5 billion (US$422.13 million). The recovery was attributed to restructuring, cost cuts and improved margins rather than strong product demand; like-for-like sales grew 0.7%. Shiseido raised its full-year core operating profit forecast from ¥59 billion (US$433 million) to ¥87 billion (US$546 million).

Reported by Mira Solen, Skincare Formulation Analyst.